Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis.

Saved in:
Bibliographic Details
Title: Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis.
Authors: Kornilov SA; Institute for Systems Biology, WA, USA., Price ND; Institute for Systems Biology, WA, USA; Buck Institute for Research on Aging, CA, USA., Gelinas R; Institute for Systems Biology, WA, USA., Acosta J; Roche Genentech, Inc, CA, USA., Brunkow ME; Institute for Systems Biology, WA, USA., Gervasi-Follmar T; Providence Multiple Sclerosis Center, OR, USA., Winger RC; Roche Genentech, Inc, CA, USA., Aldershoff D; Roche Genentech, Inc, CA, USA., Lausted C; Institute for Systems Biology, WA, USA., Troisch P; Institute for Systems Biology, WA, USA., Smith B; Institute for Systems Biology, WA, USA., Heath JR; Institute for Systems Biology, WA, USA., Repovic P; Swedish Medical Center, WA, USA., Cohan S; Providence Multiple Sclerosis Center, OR, USA., Magis AT; Institute for Systems Biology, WA, USA. Electronic address: andrew.magis@isbscience.org.
Source: Journal of the neurological sciences [J Neurol Sci] 2024 Dec 15; Vol. 467, pp. 123303. Date of Electronic Publication: 2024 Nov 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5883
DOI:10.1016/j.jns.2024.123303